BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu SY, Wu FG, Chen X. Antibody-Incorporated Nanomedicines for Cancer Therapy. Adv Mater 2022;:e2109210. [PMID: 35142395 DOI: 10.1002/adma.202109210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Dong S, Zhang Y, Guo X, Zhang C, Wang Z, Yu J, Liu Y, Li C, Hu Y, Sun B, Sun M, Zhang H, Ouyang D, He Z, Wang Y. Glutathione Pulse Therapy: Promote Spatiotemporal Delivery of Reduction-Sensitive Nanoparticles at the "Cellular Level" and Synergize PD-1 Blockade Therapy. Adv Sci (Weinh) 2022;:e2202744. [PMID: 35896947 DOI: 10.1002/advs.202202744] [Reference Citation Analysis]
2 Mittelheisser V, Coliat P, Moeglin E, Goepp L, Goetz JG, Charbonnière LJ, Pivot X, Detappe A. Optimal Physicochemical Properties of Antibody-Nanoparticle Conjugates for Improved Tumor Targeting. Adv Mater 2022;:e2110305. [PMID: 35289003 DOI: 10.1002/adma.202110305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]